Artificial intelligence-driven drug repositioning uncovers efavirenz as a modulator of α-synuclein propagation: Implications in Parkinson's disease

This study opens new avenues for further investigation into the mechanisms underlying PD pathology and the exploration of additional drug candidates using advanced computational methodologies.PMID:38513596 | DOI:10.1016/j.biopha.2024.116442

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - March 21, 2024 Category: Drugs & Pharmacology Authors: Jae-Bong Kim Soo-Jeong Kim Minyoung So Dong-Kyu Kim Hye Rin Noh Beom Jin Kim Yu Ree Choi Doyoon Kim Heejung Koo Taeyong Kim Hyun Goo Woo Sang Myun Park Source Type: research